Summary
"TrendSights Analysis: Informed Shopping - Meeting the needs of informed and critical consumers" examines the ways that information and informed shopping influences shopping habits and product choice. It look at what informed shopping means as a consumer trend, why it is important, who the relevant consumers are, how FMCG brands can best capitalize on the trend, and the future outlook of the trend. Click For Report Details @ http://www.radiantinsights.com/research/trendsights-analysis-informed-shopping-meeting-the-needs-of-informed-and-critical-consumers The availability of information through novel technologies has raised consumer awareness about the social impact of shopping decisions. In a circular process, consumer awareness drives the creation of new platforms and increasingly granular sources of information. Consumers now have instant access to comparisons of price, product quality, and brand ethics. This changes how consumers shop and how they perceive brands and products. Scope • Information coming from online reviews, social media, and other online sources combined with the accessibility of information on mobile devices is reshaping consumer shopping habits. • 79% of consumers check prices online before making a purchase. • 56% of consumers use price comparison websites to compare different prices at supermarkets. • 55% of consumers are more likely to trust blogger/user reviews over brand claims. • 45% of consumers are willing to boycott a brand whose values do not reflect their own. Reasons To Buy • Understand which audiences are most affected by the Informed Shopping trend. • Compare the presence of this trend in each industry across the FMCG space, and learn what the key opportunities are. • See the steps that major brands are taking to meet the needs of informed shoppers. See More Reports of This Category by Radiant Insights @ http://www.radiantinsights.com/catalog/consumer-goods About Radiant Insights, Inc Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions. Contact Details: Michelle Thoras Corporate Sales Specialist, USA Radiant Insights, Inc Phone: 1-415-349-0054 Toll Free: 1-888-202-9519 Email: [email protected] Web: http://www.radiantinsights.com/
0 Comments
Summary
"TrendSights Analysis: Guided Health", explores what the Guided Health trend is, why it is important, who is most influenced by it, and how brands and manufacturers can capitalize on it. The research concludes by identifying where the trend is heading next and how long it will last. In the "information economy," health-conscious consumers now more confidently embrace an abundance of new information tools, enabling more health-driven choices. Consumers are seeking conveniences that make it easier to reach their health goals, including functional health products and more transparent nutritional labeling to guide them towards their health targets. Click For Report Details @ http://www.radiantinsights.com/research/trendsights-analysis-guided-health Scope • Over half of consumers globally are concerned about the impact of diet on health and appearance. • Over three quarters of consumers globally are interested in food and drinks that improve general health and wellbeing. • Over a third of consumers globally find knowing what food and drinks are healthy for them confusing. Reasons To Buy • Understand the relevant consumer trends and attitudes that drive and support innovation success so you can tap into what is really impacting the industry. • Gain a broader appreciation of the fast-moving consumer goods industry by gaining insights from both within and outside of your sector. • Access valuable strategic take-outs to help direct future decision-making and inform new product development. See More Reports of This Category by Radiant Insights @ http://www.radiantinsights.com/catalog/consumer-goods About Radiant Insights, Inc Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions. Contact Details: Michelle Thoras Corporate Sales Specialist, USA Radiant Insights, Inc Phone: 1-415-349-0054 Toll Free: 1-888-202-9519 Email: [email protected] Web: http://www.radiantinsights.com/ Summary
The global Seasonings, Dressings & Sauces sector was valued at US$99.5 billion in 2016 and is forecast to record a CAGR of 5.4% during 2016-2021 to reach US$129.6 billion by 2021. Asia-Pacific represented the largest region for the global Seasonings, Dressings & Sauces sector with a value share of 36.8% in 2016. The region is also forecast to record the fastest CAGR of 8.2% during 2016-2021. A growing population, rising urbanization rate, and improving economy will remain the primary macroeconomic factors driving the sector globally. Condiment Sauces is forecast to be the fastest growing market for Seasonings, Dressings & Sauces, given the convenience of adding flavors instantaneously, especially among consumers looking to enjoy authentic flavors in home-cooked meals without investing much time or effort. However, negative consumer perception about Seasonings, Dressings & Sauces as being unhealthy due to the presence of preservatives and excess sugar and sodium levels pose a major challenge for manufacturers, particularly in developing countries. Click For Report Details @ http://www.radiantinsights.com/research/opportunities-in-the-global-seasonings-dressings-and-sauces-sector-analysis-of-opportunities-offered-by-high-growth-economies This report brings together multiple data sources to provide a comprehensive overview of the global Seasonings, Dressings & Sauces sector as part of our global series. It includes an analysis on global Seasonings, Dressings & Sauces sector with consumption analysis highlighted for all regions. The report also identifies high potential countries across regions that have been identified by creating a risk-reward analysis with multiple parameters. Scope • The report provides an overview of global and regional markets covering - Asia-Pacific, Middle East & Africa, North America, Latin America, Western Europe, and Eastern Europe - highlighting sector size, growth drivers, latest developments, and future inhibitors for the region. • It also identifies top ten high potential countries and provides deep dive analysis of top two countries in each region. • The report draws on the sector data by analyzing key distribution channels for Seasonings, Dressings & Sauces in the global market. • Sector data is also used for studying the level of competition in the sector by identifying the top brands at a global and regional level with insights on sector shares of private label products. • The report also includes insights on Health & Wellness products in terms of value and percentage share in the overall Meat sector at global and regional level during 2011-2021. Reasons To Buy • To have a thorough fact based analysis with information about the global Seasonings, Dressings & Sauces sector across the six regions in value terms and the underlying factors that are driving the sales • To gain confidence to make the correct business decisions based on a detailed analysis of the global Seasonings, Dressings & Sauces sector and to identify high potential countries over the next 5 years • The analysts have placed a significant emphasis on the mega trends that drive consumer choice and will provide a clear picture about the future opportunities that can be explored across the region, resulting in revenue expansion • To gain competitive intelligence about leading brands in the Seasonings, Dressings & Sauces sector at global and regional level with information about their market share, business descriptions and product profiles See More Reports of This Category by Radiant Insights @ http://www.radiantinsights.com/catalog/consumer-goods About Radiant Insights, Inc Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions. Contact Details: Michelle Thoras Corporate Sales Specialist, USA Radiant Insights, Inc Phone: 1-415-349-0054 Toll Free: 1-888-202-9519 Email: [email protected] Web: http://www.radiantinsights.com/ Summary
Consumer and Market Insights report on "Opportunities in the Global Meat Sector", provides insights on high growth categories to target, trends in the usage of packaging materials, types and closures category level distribution data and brands shares. The global Meat sector was valued at US$909.3 billion in 2016 and is forecast to record a CAGR of 2.4% during 2016-2021 to reach US$1 trillion by 2021. Asia-Pacific represents the largest regional market, with a value share of 31% in the global Meat sector in 2016. The region is also forecast to record the fastest CAGR of 3.8% during 2016-2021. Improving worldwide economies and rising consumption of Meat from an expanding global population, will continue to be major drivers for the global Meat sector. Despite the rising consumption of Meat worldwide, the ecological concerns regarding Meat production, known to be a major source of carbon emissions, will remain a challenge for the sector as consumers shift towards more eco-friendly diets such as plant-based protein. Click For Report Details @ http://www.radiantinsights.com/research/opportunities-in-the-global-meat-sector-analysis-of-opportunities-offered-by-high-growth-economies What else is contained? • Sector data: Overall alue and volume data with growth analysis for 2011-2021 • Market coverage: Value and growth analysis with inputs on individual category share within each market and the change in their sector share forecast for 2016-2021 • More extensive brand coverage: The report provides more extensive brand share coverage. Brand share data is also validated by inputs from industry experts. • Distribution channel: The Distribution data included in the report covers 11 distribution channels including: Hypermarkets & Supermarkets, Food & Drinks Specialists, Department Stores, Cash & Carries & Warehouse Clubs, "Dollar Stores" and Variety Stores & General Merchandise Retailers. • Packaging data: consumption breakdown for packaging materials and containers in each category, in terms of percentage share of number of units sold. Packaging material data for Rigid Plastics, Flexible Packaging, Rigid Plastics, Rigid Metal and Paper & Board; container data for: Film, Tray, Tub, Bag/Sachet and others • Consumer level trends: Top four consumer trends which influence Meat products consumption • Future outlook: Reviews and recommendations on how the market will shape up from 2016-2021 • Recommendations for manufacturers on key Meat categories Cooked Meats Counter, Ambient Meat, Fresh Meat (Counter), Frozen Meat, Chilled Raw Packaged Meat Processed, Chilled Raw Packaged Meat Whole Cuts and Cooked Meats Packaged with inputs on individual segment share within each category and the change in their market share forecast for 2016-2021 Scope • Global Meat sector: Improving global economy supports growth in packaged Meat sector worldwide • Drivers for a shift in consumption patterns: Health and environmental concerns will impact the value share of Meat in the food industry • Asia-Pacific: The region is is forecast to be the largest and fastest-growing market for the global Meat sector in value terms • In Latin America, Stable herd production will keep up the demand for Meat products • Eastern Europe: Busy lifestyles spur interest in convenient formats of Meat products • Hypermarkets & Supermarkets is the leading distribution channel in the global Meat sector • Film is the most commonly used closure type in the global Meat sector See More Reports of This Category by Radiant Insights @ http://www.radiantinsights.com/catalog/consumer-goods About Radiant Insights, Inc Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions. Contact Details: Michelle Thoras Corporate Sales Specialist, USA Radiant Insights, Inc Phone: 1-415-349-0054 Toll Free: 1-888-202-9519 Email: [email protected] Web: http://www.radiantinsights.com/ Summary
Consumer and Market Insights report on the Global Prepred Meals sector provides insights on high growth categories to target, trends in the usage of packaging materials, types and closures category level distribution data and brands shares. Click For Report Details @ http://www.radiantinsights.com/research/opportunities-in-the-global-prepared-meals-sector The global Prepared Meals sector was valued at US$83.4 billion in 2016 and is forecast to record a CAGR of 3.5% during 2016-2021 to reach US$99.1 billion by 2021. Western Europe represented the largest regional market with a value share of 39.5% in the global Prepared Meals sector in 2016, while Asia-Pacific is forecast to record the fastest CAGR of 6.5% during 2016-2021. The global Prepared Meals sector is witnessing increased competition from other food sectors, particularly Dairy Foods and Savory Snacks, as consumers become busier and choose a quick, healthy alternative over Prepared Meals, especially when consuming food out-of-home. What else is contained? • Sector data: Overall alue and volume data with growth analysis for 2011-2021 • Market coverage: Value and growth analysis with inputs on individual category share within each market and the change in their sector share forecast for 2016-2021 • More extensive brand coverage: The report provides more extensive brand share coverage. Brand share data is also validated by inputs from industry experts. • Distribution channel: The Distribution data included in the report covers 11 distribution channels including Hypermarkets & Supermarkets, Food & Drinks Specialists, Department Stores, Cash & Carries & Warehouse Clubs, "Dollar Stores" and Variety Stores & General Merchandise Retailers. • Packaging data: consumption breakdown for packaging materials and containers in each category, in terms of percentage share of number of units sold. Packaging material data for Rigid Plastics, Flexible Packaging, Rigid Plastics, Rigid Metal and Paper & Board; container data for: Film, Tray, Tub, Bag/Sachet and others • Consumer level trends: Top four consumer trends which influence Prepared Meals products consumption • Future outlook: Reviews and recommendations on how the market will shape up from 2016-2021 • Recommendations for manufacturers on key Prepared Meals categories - Meal Kits, Pizza, and Ready Meals with inputs on individual segment share within each category and the change in their market share forecast for 2016-2021 Scope • Global Prepared Meals sector: Improving global economy, supported by stronger than expected growth revival in advanced economies drives demand for Prepared Meals • Drivers for a shift in consumption patterns: Changing dietary preferences will impact the value share of Prepared Meals in the food industry • Asia-Pacific: The region is forecast to become the second largest regional market for the global Prepared Meals sector in value terms • In Latin America, Colombia and Brazil are set to drive growth in Prepared Meals in value terms • Eastern Europe is a highly fragmented market with top four brands accounting only for 14.5% of value sales • Hypermarkets & Supermarkets is the leading distribution channel in the global Prepared Meals sector • Film is the most commonly used closure type in the global Prepared Meals sector See More Reports of This Category by Radiant Insights @ http://www.radiantinsights.com/catalog/consumer-goods About Radiant Insights, Inc Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions. Contact Details: Michelle Thoras Corporate Sales Specialist, USA Radiant Insights, Inc Phone: 1-415-349-0054 Toll Free: 1-888-202-9519 Email: [email protected] Web: http://www.radiantinsights.com/ Summary
Latest Pharmaceutical and Healthcare disease pipeline guide House Dust Mite Allergy Pipeline Review, H1 2017, provides an overview of the House Dust Mite Allergy (Immunology) pipeline landscape. House dust mite allergy is an allergic reaction to tiny bugs that commonly live in house dust. Symptoms include frequent sneezing, a runny, stuffy, itchy nose and irritated eyes. Asthma and eczema can also be triggered by a dust mite allergy. Symptoms often worsen when the individual comes in close proximity to disturbed dust. The predisposing factors include family history and age. Treatment includes antihistamines, decongestants and corticosteroids. View Full Report with TOC @ http://www.radiantinsights.com/research/house-dust-mite-allergy-pipeline-review-h1-2017 Report Highlights The Pharmaceutical and Healthcare latest pipeline guide House Dust Mite Allergy Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for House Dust Mite Allergy (Immunology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. The House Dust Mite Allergy (Immunology) pipeline guide also reviews of key players involved in therapeutic development for House Dust Mite Allergy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, IND/CTA Filed, Preclinical and Discovery stages are 1, 2, 2, 1, 2 and 1 respectively. House Dust Mite Allergy (Immunology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. Scope • The pipeline guide provides a snapshot of the global therapeutic landscape of House Dust Mite Allergy (Immunology). • The pipeline guide reviews pipeline therapeutics for House Dust Mite Allergy (Immunology) by companies and universities/research institutes based on information derived from company and industry-specific sources. • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. • The pipeline guide reviews key companies involved in House Dust Mite Allergy (Immunology) therapeutics and enlists all their major and minor projects. • The pipeline guide evaluates House Dust Mite Allergy (Immunology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. • The pipeline guide encapsulates all the dormant and discontinued pipeline projects. • The pipeline guide reviews latest news related to pipeline therapeutics for House Dust Mite Allergy (Immunology) Reasons To Buy • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies. • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. • Find and recognize significant and varied types of therapeutics under development for House Dust Mite Allergy (Immunology). • Classify potential new clients or partners in the target demographic. • Develop tactical initiatives by understanding the focus areas of leading companies. • Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics. • Formulate corrective measures for pipeline projects by understanding House Dust Mite Allergy (Immunology) pipeline depth and focus of Indication therapeutics. • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline. See More Reports of This Category by Radiant Insights @ http://www.radiantinsights.com/catalog/pharmaceuticals-and-healthcare About Radiant Insights, Inc Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions. Contact Details: Michelle Thoras Corporate Sales Specialist, USA Radiant Insights, Inc Phone: 1-415-349-0054 Toll Free: 1-888-202-9519 Email: [email protected] Web: http://www.radiantinsights.com/ Summary
Latest Pharmaceutical and Healthcare disease pipeline guide Nasopharyngitis (Common Cold) Pipeline Review, H1 2017, provides an overview of the Nasopharyngitis (Common Cold) (Ear Nose Throat Disorders) pipeline landscape. Nasopharyngitis also known as common cold is an infectious, inflammatory condition that affects the throat and nasal passages. The virus can spread through droplets in the air when someone who is sick coughs, sneezes or talks. Symptoms include sore throat, runny nose, sneezing, fatigue, headache and loss of appetite. Risk factors include age and weakened immune system. Treatment includes pain relievers and decongestant medications. View Full Report with TOC @ http://www.radiantinsights.com/research/nasopharyngitis-common-cold-pipeline-review-h1-2017 Report Highlights The Pharmaceutical and Healthcare latest pipeline guide Nasopharyngitis (Common Cold) Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Nasopharyngitis (Common Cold) (Ear Nose Throat Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. The Nasopharyngitis (Common Cold) (Ear Nose Throat Disorders) pipeline guide also reviews of key players involved in therapeutic development for Nasopharyngitis (Common Cold) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration and Preclinical stages are 2 and 5 respectively. Similarly, the Universities portfolio in Discovery stages comprises 2 molecules, respectively. Nasopharyngitis (Common Cold) (Ear Nose Throat Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. Scope
Reasons To Buy
About Radiant Insights, Inc Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions. Contact Details: Michelle Thoras Corporate Sales Specialist, USA Radiant Insights, Inc Phone: 1-415-349-0054 Toll Free: 1-888-202-9519 Email: [email protected] Web: http://www.radiantinsights.com/ Summary
Latest Pharmaceutical and Healthcare disease pipeline guide Restless Legs Syndrome Pipeline Review, H1 2017, provides an overview of the Restless Legs Syndrome (Central Nervous System) pipeline landscape. Restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED), is a disorder of the part of the nervous system that affects the legs and causes an urge to move them. Symptoms include itching, pain, a creepy-crawly feeling and cramping in the calf's or legs. Predisposing factor includes age. Treatment includes muscle relaxants, sleep medications and narcotic medications. View Full Report with TOC @ http://www.radiantinsights.com/research/restless-legs-syndrome-pipeline-review-h1-2017 Report Highlights The Pharmaceutical and Healthcare latest pipeline guide Restless Legs Syndrome Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Restless Legs Syndrome (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. The Restless Legs Syndrome (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Restless Legs Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I and Preclinical stages are 1, 1, 3, 1 and 1 respectively. Restless Legs Syndrome (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. Scope • The pipeline guide provides a snapshot of the global therapeutic landscape of Restless Legs Syndrome (Central Nervous System). • The pipeline guide reviews pipeline therapeutics for Restless Legs Syndrome (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources. • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. • The pipeline guide reviews key companies involved in Restless Legs Syndrome (Central Nervous System) therapeutics and enlists all their major and minor projects. • The pipeline guide evaluates Restless Legs Syndrome (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. • The pipeline guide encapsulates all the dormant and discontinued pipeline projects. • The pipeline guide reviews latest news related to pipeline therapeutics for Restless Legs Syndrome (Central Nervous System) Reasons To Buy • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies. • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. • Find and recognize significant and varied types of therapeutics under development for Restless Legs Syndrome (Central Nervous System). • Classify potential new clients or partners in the target demographic. • Develop tactical initiatives by understanding the focus areas of leading companies. • Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics. • Formulate corrective measures for pipeline projects by understanding Restless Legs Syndrome (Central Nervous System) pipeline depth and focus of Indication therapeutics. • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline. See More Reports of This Category by Radiant Insights @ http://www.radiantinsights.com/catalog/pharmaceuticals-and-healthcare About Radiant Insights, Inc Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions. Contact Details: Michelle Thoras Corporate Sales Specialist, USA Radiant Insights, Inc Phone: 1-415-349-0054 Toll Free: 1-888-202-9519 Email: [email protected] Web: http://www.radiantinsights.com/ Summary
Latest Pharmaceutical and Healthcare disease pipeline guide Hidradenitis Suppurativa Pipeline Review, H1 2017, provides an overview of the Hidradenitis Suppurativa (Dermatology) pipeline landscape. Hidradenitis suppurativa is a chronic skin condition that features pea-sized to marble-sized lumps under the skin. Also known as acne inversa, these deep-seated lumps typically develop where skin rubs together such as the armpits, groin, between the buttocks and under the breasts. View Full Report with TOC @ http://www.radiantinsights.com/research/hidradenitis-suppurativa-pipeline-review-h1-2017 Report Highlights The Pharmaceutical and Healthcare latest pipeline guide Hidradenitis Suppurativa Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Hidradenitis Suppurativa (Dermatology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. The Hidradenitis Suppurativa (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Hidradenitis Suppurativa and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical and Unknown stages are 1, 2, 4, 1, 8 and 1 respectively. Hidradenitis Suppurativa (Dermatology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. Scope • The pipeline guide provides a snapshot of the global therapeutic landscape of Hidradenitis Suppurativa (Dermatology). • The pipeline guide reviews pipeline therapeutics for Hidradenitis Suppurativa (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources. • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. • The pipeline guide reviews key companies involved in Hidradenitis Suppurativa (Dermatology) therapeutics and enlists all their major and minor projects. • The pipeline guide evaluates Hidradenitis Suppurativa (Dermatology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. • The pipeline guide encapsulates all the dormant and discontinued pipeline projects. • The pipeline guide reviews latest news related to pipeline therapeutics for Hidradenitis Suppurativa (Dermatology) Reasons To Buy • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies. • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. • Find and recognize significant and varied types of therapeutics under development for Hidradenitis Suppurativa (Dermatology). • Classify potential new clients or partners in the target demographic. • Develop tactical initiatives by understanding the focus areas of leading companies. • Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics. • Formulate corrective measures for pipeline projects by understanding Hidradenitis Suppurativa (Dermatology) pipeline depth and focus of Indication therapeutics. • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline. See More Reports of This Category by Radiant Insights @ http://www.radiantinsights.com/catalog/pharmaceuticals-and-healthcare About Radiant Insights, Inc Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions. Contact Details: Michelle Thoras Corporate Sales Specialist, USA Radiant Insights, Inc Phone: 1-415-349-0054 Toll Free: 1-888-202-9519 Email: [email protected] Web: http://www.radiantinsights.com/ Summary
Latest Pharmaceutical and Healthcare disease pipeline guide Traumatic Brain Injury Pipeline Review, H1 2017, provides an overview of the Traumatic Brain Injury (Central Nervous System) pipeline landscape. Traumatic brain injury happens when an external mechanical force causes brain damage. Traumatic brain injury usually results from a violent blow or jolt to the head or body. Symptoms include headache, dizziness, nausea or vomiting, mood changes, fatigue or drowsiness, difficulty sleeping and memory or concentration problems. Risk factor includes age. Certain types of traumatic brain injury increase the risk of developing Alzheimer's disease and coordination problems. View Full Report with TOC @ http://www.radiantinsights.com/research/traumatic-brain-injury-pipeline-review-h1-2017 Report Highlights The Pharmaceutical and Healthcare latest pipeline guide Traumatic Brain Injury Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Traumatic Brain Injury (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. The Traumatic Brain Injury (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Traumatic Brain Injury and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 1, 7, 3, 1, 56 and 10 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 11 and 1 molecules, respectively. Traumatic Brain Injury (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. Scope • The pipeline guide provides a snapshot of the global therapeutic landscape of Traumatic Brain Injury (Central Nervous System). • The pipeline guide reviews pipeline therapeutics for Traumatic Brain Injury (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources. • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. • The pipeline guide reviews key companies involved in Traumatic Brain Injury (Central Nervous System) therapeutics and enlists all their major and minor projects. • The pipeline guide evaluates Traumatic Brain Injury (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. • The pipeline guide encapsulates all the dormant and discontinued pipeline projects. • The pipeline guide reviews latest news related to pipeline therapeutics for Traumatic Brain Injury (Central Nervous System) Reasons To Buy • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies. • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. • Find and recognize significant and varied types of therapeutics under development for Traumatic Brain Injury (Central Nervous System). • Classify potential new clients or partners in the target demographic. • Develop tactical initiatives by understanding the focus areas of leading companies. • Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics. • Formulate corrective measures for pipeline projects by understanding Traumatic Brain Injury (Central Nervous System) pipeline depth and focus of Indication therapeutics. • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline. See More Reports of This Category by Radiant Insights @ http://www.radiantinsights.com/catalog/pharmaceuticals-and-healthcare About Radiant Insights, Inc Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions. Contact Details: Michelle Thoras Corporate Sales Specialist, USA Radiant Insights, Inc Phone: 1-415-349-0054 Toll Free: 1-888-202-9519 Email: [email protected] Web: http://www.radiantinsights.com/ |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
June 2017
Categories |